Your browser doesn't support javascript.
loading
Negative myoclonus as the leading symptom in acute cefepime neurotoxicity.
Zimmermann, Philipp; Camenzind, Dominik; Beer, Jürg Hans; Tarnutzer, Alexander Andrea.
Afiliación
  • Zimmermann P; Internal Medicine, Kantonsspital Baden, Baden, Switzerland.
  • Camenzind D; Internal Medicine, Kantonsspital Baden, Baden, Switzerland.
  • Beer JH; Internal Medicine, Kantonsspital Baden, Baden, Switzerland.
  • Tarnutzer AA; Neurology, Kantonsspital Baden, Baden, Switzerland atarnutzer@gmail.com.
BMJ Case Rep ; 14(4)2021 Apr 08.
Article en En | MEDLINE | ID: mdl-33832932
An 86-year-old woman was diagnosed with hospital-acquired pneumonia with Pseudomonas aeruginosa and treated with cefepime adjusted to her renal clearance. After 4 days, she developed acute-onset negative myoclonus without signs of altered mental status. After ruling out an acute intracranial haemorrhagic or ischaemic stroke as well as other metabolic and endocrine causes of negative myoclonus, the antibiotic was switched to piperacillin/tazobactam due to a suspicion of cefepime neurotoxicity. The patient improved within 24 hours and her symptoms fully resolved within 4 days. These observations suggest a link of the negative myoclonus to acute cefepime neurotoxicity, which may occur without or with minimal alteration of mental status, thus extending its spectrum of clinical presentation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Isquemia Encefálica / Accidente Cerebrovascular / Mioclonía Tipo de estudio: Diagnostic_studies Límite: Aged80 / Female / Humans Idioma: En Revista: BMJ Case Rep Año: 2021 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Isquemia Encefálica / Accidente Cerebrovascular / Mioclonía Tipo de estudio: Diagnostic_studies Límite: Aged80 / Female / Humans Idioma: En Revista: BMJ Case Rep Año: 2021 Tipo del documento: Article País de afiliación: Suiza
...